Cargando…
EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
BACKGROUND: Previous research indicated that the tumor cells and microenvironment interactions are critical for the immunotherapeutic response. However, predicting the clinical response to immunotherapy remains a dilemma for clinicians. Hence, this study aimed to investigate the associations between...
Autores principales: | Qu, Shanqiang, Liu, Jin, Wang, Huafu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056259/ https://www.ncbi.nlm.nih.gov/pubmed/33889156 http://dx.doi.org/10.3389/fimmu.2021.648416 |
Ejemplares similares
-
EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
por: Hu, Zhicheng, et al.
Publicado: (2021) -
N6‐methyladenine‐related genes affect biological behavior and the prognosis of glioma
por: Qu, Shanqiang, et al.
Publicado: (2020) -
PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma
por: Wang, Jinxiang, et al.
Publicado: (2023) -
Prognostic significance of cancer stemness‐associated genes in patients with gliomas
por: Qu, Shanqiang, et al.
Publicado: (2020) -
Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas
por: Li, Junhong, et al.
Publicado: (2023)